Potential bias of preoperative intravitreal anti-VEGF injection for complications of proliferative diabetic retinopathy.
<h4>Purpose</h4>Intravitreal anti-VEGF injection (IVI) is administered before vitrectomy to assist management of proliferative diabetic retinopathy (PDR)-related complications. In the clinical setting, retinal surgeons determine the use of preoperative IVI based on individual criteria. I...
Saved in:
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/eb6c180c79794c898f39cfa4ae99e127 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|